Which of the following statements is true regarding anemia of prematurity?
A 30-week preterm neonate is admitted to NICU immediately after birth. Which of the following complications is MOST directly related to surfactant deficiency?
The recommended ambient temperature for NICU is
What is the recommended rate for blood transfusion in neonates?
What is the correct dose of i.v. adrenaline in term infants during neonatal resuscitation?
Which of the following is a common symptom of neonatal lupus?
What is the primary reason for low glucose levels in premature infants?
Maximum concentration of dextrose that can be given through peripheral vascular line in neonate?
What is the most common cause of conjugated hyperbilirubinemia in infants?
Neonatal conjunctivitis is caused by all of the following except:
Explanation: ***Low reticulocyte response*** - Anemia of prematurity results from several factors, including a **blunted erythropoietin response** to anemia, **shortened red blood cell lifespan**, and **rapid growth with increased blood volume requirements**. - The combination of these factors leads to **insufficient red blood cell production** by the bone marrow, reflected by a **low reticulocyte count** despite anemia. - This low reticulocyte response is a **key diagnostic feature** distinguishing it from hemolytic anemias. *Hemoglobin level <10 gm/dL* - While premature infants with anemia of prematurity develop low hemoglobin, a specific cutoff of **<10 gm/dL is not universally definitive** for diagnosis. - Hemoglobin nadirs vary based on **gestational age** (more premature = lower nadir) and occur at different postnatal ages. - Transfusion thresholds are determined by **clinical stability and symptoms**, not just a single Hb value. *10 ml/kg packed cell transfusion* - This describes a **treatment intervention**, not a characteristic of the disease itself. - Transfusion volume is typically **10-15 ml/kg** when indicated, but the decision to transfuse depends on gestational age, postnatal age, clinical stability, and symptoms like apnea or bradycardia. - This is **not a defining feature** of anemia of prematurity. *Microcytic hypochromic type* - Anemia of prematurity is typically **normocytic, normochromic**, not microcytic hypochromic. - **Microcytic hypochromic** anemia suggests **iron deficiency**, which is a different condition. - The red cells in anemia of prematurity have **normal size (MCV) and normal hemoglobin content** per cell.
Explanation: ***Increased risk of respiratory distress syndrome*** - RDS is **most directly caused by surfactant deficiency** in preterm infants, as surfactant production begins around 24-28 weeks and becomes adequate only by 34-36 weeks of gestation. - Surfactant reduces **surface tension in alveoli**, preventing alveolar collapse during expiration. Without adequate surfactant, there is diffuse atelectasis and impaired gas exchange. - Clinical features include **tachypnea, grunting, intercostal retractions, and cyanosis** typically appearing within the first few hours of life. - Chest X-ray shows characteristic **ground-glass appearance with air bronchograms**. *Increased risk of hypothermia* - While preterm infants are indeed at risk for hypothermia due to **large surface area-to-body mass ratio, reduced brown fat, and immature thermoregulation**, this is not directly related to surfactant deficiency. - Hypothermia is primarily related to **thermal regulation mechanisms** rather than lung maturity. *Increased risk of hypoglycemia* - Preterm babies have **limited glycogen stores and immature gluconeogenesis**, increasing hypoglycemia risk. - However, this is related to **metabolic and hepatic immaturity**, not surfactant deficiency. *Increased risk of intraventricular hemorrhage* - Preterm infants are at risk for IVH due to **fragile germinal matrix capillaries and fluctuating cerebral blood flow**. - This is a **neurovascular complication**, not directly related to surfactant deficiency, though severe RDS with hypoxia can be a contributing factor.
Explanation: ***22-26° C*** - Maintaining an ambient temperature of **22-26°C** in the NICU is crucial for preventing **cold stress** in neonates. - This temperature range helps to maintain the baby's **core body temperature**, reducing metabolic demands and ensuring optimal thermal regulation. *20-22° C* - While this might be a comfortable room temperature for adults, it is generally **too cold** for newborns in the NICU. - Temperatures below the recommended range can lead to significant **cold stress**, increasing oxygen consumption and metabolic rate in vulnerable infants. *26-30° C* - This temperature range is generally **too warm** for a NICU environment. - Excessive warmth can lead to **hyperthermia** and sweating, which increases fluid loss and can be detrimental to a neonate's health. *30-35°C* - This temperature is **dangerously high** for neonates in the NICU. - Such high temperatures would significantly increase the risk of **hyperthermia, dehydration**, and other severe complications, compromising the infant's well-being.
Explanation: ***1-5 ml/min*** - The recommended rate for blood transfusion in neonates is **1-5 ml/min** to prevent **circulatory overload** and other complications. - Slower rates are crucial for neonates due to their limited cardiovascular reserves and smaller blood volume. *5-10 ml/min* - This rate is generally **too fast** for routine neonatal blood transfusions, increasing the risk of **fluid overload** and **cardiac strain**. - Rapid administration can lead to complications such as **necrotizing enterocolitis (NEC)** or **respiratory distress**. *10-15 ml/min* - Administering blood at this rate in neonates is **contraindicated** due to the high risk of **cardiovascular compromise**. - It could quickly overwhelm the neonate's circulatory system, leading to severe adverse events. *15-20 ml/min* - This rate is significantly **too rapid** for any neonatal blood transfusion and would almost certainly result in **severe volume overload** and potential cardiac arrest. - Such high rates are only rarely considered in extreme emergency situations, like massive hemorrhage with specific considerations and monitoring.
Explanation: ***0.1-0.3 ml/kg in 1:10,000*** - The recommended intravenous adrenaline dose for neonatal resuscitation is **0.01-0.03 mg/kg** using a **1:10,000 solution (0.1 mg/mL)**. - Volume calculation: 0.01-0.03 mg/kg ÷ 0.1 mg/mL = **0.1-0.3 mL/kg**. - This is the standard dose as per **NRP (Neonatal Resuscitation Program)** and **AHA guidelines** [2]. - The 1:10,000 concentration is safer for IV/umbilical venous catheter administration in neonates. *0.01-0.03 ml/kg in 1:1,000* - This volume is far too low for a 1:1,000 solution. - Would deliver only 0.01-0.03 mg total (not per kg), resulting in a **sub-therapeutic dose**. - The 1:1,000 concentration contains 1 mg/mL, which is **10 times more concentrated** than the recommended dilution. *0.3-0.5 ml/kg in 1:10,000* - This volume would deliver 0.03-0.05 mg/kg, which **exceeds the recommended maximum** of 0.03 mg/kg. - Higher doses can cause **severe adverse effects** including hypertension, arrhythmias, decreased myocardial function, and compromised coronary perfusion. - Not recommended as the standard initial dose. *0.03-0.05 ml/kg in 1:1,000* - The 1:1,000 concentration (1 mg/mL) is **too concentrated for IV use** in neonates [1]. - This volume would deliver 0.03-0.05 mg/kg from a highly concentrated solution, increasing risk of **severe cardiovascular complications**. - The 1:1,000 solution is reserved for **endotracheal administration** (at higher volumes of 0.5-1 mL/kg), not IV route.
Explanation: ***Cutaneous lesion*** - **Cutaneous lesions** are the most common manifestation of neonatal lupus, typically appearing as an **annular erythematous rash** on the face and scalp. - These lesions often develop after exposure to **ultraviolet light** and usually resolve within 6 months as maternal autoantibodies clear from the infant's system. *Thrombocytopenia* - While **hematologic abnormalities** such as thrombocytopenia can occur in neonatal lupus, they are less common than cutaneous lesions. - **Thrombocytopenia** refers to a low platelet count, which can increase the risk of bleeding. *All of the options* - While all listed options (cutaneous lesions, thrombocytopenia, and heart block) can be features of neonatal lupus, **cutaneous lesions** are the most frequently observed symptom. - Choosing "All of the options" would imply equal commonality or presence of all in every case, which is not accurate. *Heart block* - **Congenital heart block** is a serious, but less common and often irreversible, manifestation of neonatal lupus, caused by maternal antibodies attacking the fetal cardiac conduction system. - It usually presents as **bradycardia** and may require a pacemaker, but it is not the most common symptom overall.
Explanation: ***Decreased glycogen stores*** - Premature infants have undeveloped livers, leading to significantly **reduced glycogen reserves** at birth compared to full-term infants. - These limited stores are rapidly depleted within hours after birth, leaving the infant vulnerable to **hypoglycemia** as they cannot maintain glucose homeostasis. *Increased brain to body ratio* - While premature infants do have a relatively **larger brain-to-body ratio**, this primarily increases their glucose utilization, rather than causing low glucose directly. - The increased glucose demand is an exacerbating factor for hypoglycemia, but the fundamental issue remains the lack of available glucose to meet this demand. *Decreased action of pyruvate carboxylase* - **Pyruvate carboxylase** is an enzyme crucial for **gluconeogenesis**, the process of synthesizing glucose from non-carbohydrate precursors. - While immature hepatic enzyme systems in premature infants can contribute to impaired gluconeogenesis, the primary and most immediate reason for initial low glucose levels is the lack of stored glycogen. *None of the options* - Given that a specific and significant reason for low glucose levels in premature infants is clearly identified (decreased glycogen stores), this option is incorrect.
Explanation: ***12.5%*** - A maximum dextrose concentration of **12.5%** can typically be administered safely via a **peripheral intravenous line** in neonates. - Higher concentrations risk causing **osmotic damage** to the peripheral vein, leading to **phlebitis** and **thrombosis**. *5%* - While safe, a **5% dextrose** solution may not provide adequate caloric support for many neonates, especially those requiring significant nutritional intake. - It is used for basic hydration and to prevent hypoglycemia but often needs supplementation or higher concentrations for sustained feeding. *10%* - A **10% dextrose** solution is commonly used in neonates via peripheral lines, but concentrations up to 12.5% are generally considered the safe upper limit for extended use. - Exceeding 10% can increase the risk of phlebitis, although it is less severe than with 25%. *25%* - A **25% dextrose** concentration is highly hypertonic and should **never be administered through a peripheral line** in neonates due to the high risk of severe **phlebitis**, **vein damage**, and even **tissue necrosis** if extravasation occurs. - Such high concentrations require a **central venous catheter**.
Explanation: ***Rotor syndrome*** - Characterized by **conjugated hyperbilirubinemia** due to a defect in hepatic uptake and storage of bilirubin [1]. - This condition can lead to elevated levels of **direct (conjugated) bilirubin** without significant liver damage. *Crigler Najjar* - This condition primarily causes **unconjugated hyperbilirubinemia** due to a deficiency of the enzyme **uridine diphosphate glucuronyl transferase** [1]. - It typically presents with **kernicterus** in newborns rather than conjugated bilirubin elevation. *Breast milk jaundice* - Mainly leads to **unconjugated hyperbilirubinemia** due to substances in breast milk that inhibit bilirubin conjugation. - Generally occurs in **breastfed infants** after the first week of life, not presenting with increased conjugated bilirubin. *Gilbert syndrome* - This syndrome is associated with **unconjugated hyperbilirubinemia** due to a genetic defect in bilirubin conjugation [1]. - Typically benign, it does not cause **increased conjugated bilirubin** levels as seen in Rotor syndrome. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 860.
Explanation: ***Aspergillus*** - **Fungal infections** of the eye, particularly by *Aspergillus*, are extremely rare in neonates and typically present as **keratitis** rather than conjunctivitis. - While *Aspergillus* can cause severe infections in immunocompromised individuals, it is not a common cause of neonatal conjunctivitis. *Gonococcus* - **_Neisseria gonorrhoeae_** is a well-known cause of **ophthalmia neonatorum** (gonococcal conjunctivitis), presenting as severe, purulent discharge usually within the first 2-5 days of life. - This infection can lead to **corneal ulceration** and blindness if untreated. *Chlamydia* - **_Chlamydia trachomatis_** is the most common bacterial cause of **neonatal conjunctivitis**, typically appearing 5-14 days after birth. - It causes a **mucopurulent discharge** and can be associated with **chlamydial pneumonia** in infants. *Pseudomonas* - **_Pseudomonas aeruginosa_** can cause severe and rapidly progressive **neonatal conjunctivitis** and **keratitis**, especially in premature infants or those exposed to contaminated solutions. - It is a highly aggressive pathogen that can lead to significant ocular morbidity.
Neonatal Resuscitation
Practice Questions
Care of the Normal Newborn
Practice Questions
Prematurity and Low Birth Weight
Practice Questions
Respiratory Distress Syndrome
Practice Questions
Neonatal Jaundice
Practice Questions
Neonatal Sepsis
Practice Questions
Necrotizing Enterocolitis
Practice Questions
Intraventricular Hemorrhage
Practice Questions
Persistent Pulmonary Hypertension
Practice Questions
Perinatal Asphyxia
Practice Questions
Neonatal Seizures
Practice Questions
Congenital Anomalies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free